Infantile Cerebral Palsy: MRI and Indication for Genetic Studies
Magnetic Resonance (MRI) is essential in the evaluation of PCI. It detects anomalies in >80% of cases, allowing the etiology to be classified according to the pattern of brain damage.
MRI Patterns and Genetic Probability
- White matter injuries (50%): Periventricular leukomalacia. Generally acquired (premature, ischemia/infection). Consider genetic predisposition if there are no clear risk factors.
- Gray matter lesions (20%): Term hypoxic-ischemic encephalopathy. Acquired. Evaluate genetic factors in the absence of evident perinatal events.
- Developmental malformations (11%): Migration disorders (polymicrogyria, lysi/escenphaly). Monogenic in >80% of cases → clear indication of genetics.
- Normal MRI (11%): Temporary functional or acquired damage. High probability of underlying genetic etiology → priority genetic study.
- Miscellaneous/nonspecific: Evaluate case by case. Some findings (e.g. abnormalities in gray nuclei, cortical malformations) may indicate genetic origin.
When to Request Genetic Studies
- Clear indication: Normal MRI or malformations of brain development. Genetic study recommended in all these cases.
- Indication under consideration: Acquired lesions without clear perinatal risk factors. Genetic predisposition can increase cellular vulnerability.
- Avoid assumptions: Do not assume an undocumented cause of injury. Start genetic algorithm early if symptoms of PCI without clear perinatal history.
Source details
Horber et al., 2020: The study shows that genetic diagnostic performance is significantly higher in patients with normal MRI or developmental malformations. In these groups, up to 30-40% of cases have an identifiable monogenic cause.
SCPE classification: MRI categories allow genetic risk stratification. Acquired lesions are less likely to have a direct genetic finding, but the clinical and family context should guide the decision.
Key Keys: MRI is not only anatomical diagnosis, but also a guide for the genetic algorithm. Cases with normal MRI or malformations should be genetically evaluated as a priority.
